US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.795
  • -0.015-1.86%
Trading Dec 4 12:58 ET
99.61MMarket Cap-757P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.12%-19.45M
-49.81%-38.5M
-131.23%-43.73M
38.00%-92.72M
30.76%-18.59M
-4.09%-29.53M
26.88%-25.7M
68.06%-18.91M
-39.62%-149.55M
-205.37%-26.84M
Net income from continuing operations
7.05%-32.07M
172.91%23.79M
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
5.00%-34.51M
33.49%-32.63M
17.57%-34.13M
-33.20%-165.29M
-199.45%-38.51M
Operating gains losses
---4M
----
----
----
----
----
----
----
----
----
Depreciation and amortization
3.75%83K
9.64%91K
-70.69%85K
-14.65%530K
-31.86%77K
-56.04%80K
-44.30%83K
63.84%290K
-21.29%621K
-18.71%113K
Other non cash items
1,074.15%2.41M
647.06%1.4M
1.46%208K
54.43%820K
427.94%223K
0.99%205K
-6.50%187K
4.59%205K
-93.39%531K
-409.09%-68K
Change In working capital
1,808.74%10.48M
-685.90%-9.47M
-202.46%-10.72M
257.16%31.42M
218.01%18.79M
-48.31%549K
214.84%1.62M
140.93%10.46M
13.80%-19.99M
128.11%5.91M
-Change in receivables
210.17%6.22M
-336.75%-6.91M
-134.66%-4.12M
495.83%20.12M
8,219.26%10.96M
-42.25%-5.64M
92.99%2.92M
576.39%11.89M
47.13%-5.08M
96.40%-135K
-Change in inventory
-310.93%-1.2M
-556.13%-707K
-30.98%274K
1,100.85%1.18M
148.00%62K
172.79%567K
-61.63%155K
71.12%397K
91.93%-118K
132.47%25K
-Change in prepaid assets
-95.70%167K
202.14%565K
-338.45%-3.67M
215.43%6.67M
-51.62%1.06M
-43.51%3.89M
-74.73%187K
109.85%1.54M
76.65%-5.78M
110.08%2.2M
-Change in payables and accrued expense
182.84%5.54M
-52.88%-2.17M
5.89%-2.96M
151.95%4.35M
71.87%6.95M
309.41%1.96M
63.78%-1.42M
58.38%-3.14M
-163.78%-8.37M
-8.11%4.05M
-Change in other current assets
17.00%585K
17.50%564K
17.10%541K
16.99%1.96M
17.38%520K
17.37%500K
16.79%480K
16.37%462K
15.73%1.68M
15.67%443K
-Change in other current liabilities
-15.40%-832K
-15.08%-809K
-15.54%-788K
-24.01%-2.87M
-15.36%-766K
-27.39%-721K
-27.82%-703K
-27.24%-682K
-20.81%-2.32M
-29.94%-664K
Cash from discontinued investing activities
Operating cash flow
34.12%-19.45M
-49.81%-38.5M
-131.23%-43.73M
38.00%-92.72M
30.76%-18.59M
-4.09%-29.53M
26.88%-25.7M
68.06%-18.91M
-39.62%-149.55M
-205.37%-26.84M
Investing cash flow
Cash flow from continuing investing activities
197.25%7.47M
142.14%51.26M
167.74%21.94M
107.62%7.94M
141.11%26.84M
-165.84%-7.69M
157.85%21.17M
-130.77%-32.39M
-173.50%-104.26M
-312.21%-65.3M
Net PPE purchase and sale
--0
--0
---195K
--0
--0
--0
--0
--0
44.34%-118K
--0
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
197.25%7.47M
142.14%51.26M
168.34%22.14M
107.62%7.94M
141.11%26.84M
-165.62%-7.69M
157.85%21.17M
-132.07%-32.39M
-170.58%-104.14M
-314.25%-65.3M
Cash from discontinued investing activities
Investing cash flow
197.25%7.47M
142.14%51.26M
167.74%21.94M
107.62%7.94M
141.11%26.84M
-165.84%-7.69M
157.85%21.17M
-130.77%-32.39M
-173.50%-104.26M
-312.21%-65.3M
Financing cash flow
Cash flow from continuing financing activities
0
-99.42%1.12M
-99.83%264K
0
163.06%193.74M
17,293.19%155.84M
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
----
----
----
--0
----
----
----
----
1,816.20%189.76M
--154.68M
Proceeds from stock option exercised by employees
--0
----
----
-71.74%1.12M
-77.32%264K
--0
----
----
6.19%3.98M
29.91%1.16M
Net other financing activities
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
----
----
-99.42%1.12M
-99.83%264K
--0
----
----
163.06%193.74M
17,293.19%155.84M
Net cash flow
Beginning cash position
3.99%85.11M
-63.30%31.39M
-61.14%53.19M
-30.67%136.89M
-38.98%44.58M
-2.59%81.85M
-44.78%85.54M
-30.67%136.89M
121.55%197.45M
-47.98%73.06M
Current changes in cash
67.81%-11.98M
1,564.83%53.73M
57.53%-21.79M
-39.26%-83.66M
-86.62%8.52M
-241.48%-37.22M
94.79%-3.67M
-20.85%-51.3M
-155.43%-60.07M
11.48%63.7M
Effect of exchange rate changes
169.23%36K
57.69%-11K
64.44%-16K
93.03%-34K
-29.37%89K
25.71%-52K
94.27%-26K
50.00%-45K
-916.67%-488K
193.33%126K
End cash Position
64.12%73.17M
3.99%85.11M
-63.30%31.39M
-61.14%53.19M
-61.14%53.19M
-38.98%44.58M
-2.59%81.85M
-44.78%85.54M
-30.67%136.89M
-30.67%136.89M
Free cash flow
34.12%-19.45M
-49.81%-38.5M
-132.26%-43.92M
38.05%-92.72M
30.76%-18.59M
-3.95%-29.53M
26.88%-25.7M
68.10%-18.91M
-32.66%-149.67M
-204.17%-26.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.12%-19.45M-49.81%-38.5M-131.23%-43.73M38.00%-92.72M30.76%-18.59M-4.09%-29.53M26.88%-25.7M68.06%-18.91M-39.62%-149.55M-205.37%-26.84M
Net income from continuing operations 7.05%-32.07M172.91%23.79M-9.48%-37.36M13.43%-143.1M-8.65%-41.84M5.00%-34.51M33.49%-32.63M17.57%-34.13M-33.20%-165.29M-199.45%-38.51M
Operating gains losses ---4M------------------------------------
Depreciation and amortization 3.75%83K9.64%91K-70.69%85K-14.65%530K-31.86%77K-56.04%80K-44.30%83K63.84%290K-21.29%621K-18.71%113K
Other non cash items 1,074.15%2.41M647.06%1.4M1.46%208K54.43%820K427.94%223K0.99%205K-6.50%187K4.59%205K-93.39%531K-409.09%-68K
Change In working capital 1,808.74%10.48M-685.90%-9.47M-202.46%-10.72M257.16%31.42M218.01%18.79M-48.31%549K214.84%1.62M140.93%10.46M13.80%-19.99M128.11%5.91M
-Change in receivables 210.17%6.22M-336.75%-6.91M-134.66%-4.12M495.83%20.12M8,219.26%10.96M-42.25%-5.64M92.99%2.92M576.39%11.89M47.13%-5.08M96.40%-135K
-Change in inventory -310.93%-1.2M-556.13%-707K-30.98%274K1,100.85%1.18M148.00%62K172.79%567K-61.63%155K71.12%397K91.93%-118K132.47%25K
-Change in prepaid assets -95.70%167K202.14%565K-338.45%-3.67M215.43%6.67M-51.62%1.06M-43.51%3.89M-74.73%187K109.85%1.54M76.65%-5.78M110.08%2.2M
-Change in payables and accrued expense 182.84%5.54M-52.88%-2.17M5.89%-2.96M151.95%4.35M71.87%6.95M309.41%1.96M63.78%-1.42M58.38%-3.14M-163.78%-8.37M-8.11%4.05M
-Change in other current assets 17.00%585K17.50%564K17.10%541K16.99%1.96M17.38%520K17.37%500K16.79%480K16.37%462K15.73%1.68M15.67%443K
-Change in other current liabilities -15.40%-832K-15.08%-809K-15.54%-788K-24.01%-2.87M-15.36%-766K-27.39%-721K-27.82%-703K-27.24%-682K-20.81%-2.32M-29.94%-664K
Cash from discontinued investing activities
Operating cash flow 34.12%-19.45M-49.81%-38.5M-131.23%-43.73M38.00%-92.72M30.76%-18.59M-4.09%-29.53M26.88%-25.7M68.06%-18.91M-39.62%-149.55M-205.37%-26.84M
Investing cash flow
Cash flow from continuing investing activities 197.25%7.47M142.14%51.26M167.74%21.94M107.62%7.94M141.11%26.84M-165.84%-7.69M157.85%21.17M-130.77%-32.39M-173.50%-104.26M-312.21%-65.3M
Net PPE purchase and sale --0--0---195K--0--0--0--0--044.34%-118K--0
Net intangibles purchase and sale --------------0------------------0----
Net investment purchase and sale 197.25%7.47M142.14%51.26M168.34%22.14M107.62%7.94M141.11%26.84M-165.62%-7.69M157.85%21.17M-132.07%-32.39M-170.58%-104.14M-314.25%-65.3M
Cash from discontinued investing activities
Investing cash flow 197.25%7.47M142.14%51.26M167.74%21.94M107.62%7.94M141.11%26.84M-165.84%-7.69M157.85%21.17M-130.77%-32.39M-173.50%-104.26M-312.21%-65.3M
Financing cash flow
Cash flow from continuing financing activities 0-99.42%1.12M-99.83%264K0163.06%193.74M17,293.19%155.84M
Net issuance payments of debt --0------------------0----------------
Net common stock issuance --------------0----------------1,816.20%189.76M--154.68M
Proceeds from stock option exercised by employees --0---------71.74%1.12M-77.32%264K--0--------6.19%3.98M29.91%1.16M
Net other financing activities --0------------------------------------
Cash from discontinued financing activities
Financing cash flow --0---------99.42%1.12M-99.83%264K--0--------163.06%193.74M17,293.19%155.84M
Net cash flow
Beginning cash position 3.99%85.11M-63.30%31.39M-61.14%53.19M-30.67%136.89M-38.98%44.58M-2.59%81.85M-44.78%85.54M-30.67%136.89M121.55%197.45M-47.98%73.06M
Current changes in cash 67.81%-11.98M1,564.83%53.73M57.53%-21.79M-39.26%-83.66M-86.62%8.52M-241.48%-37.22M94.79%-3.67M-20.85%-51.3M-155.43%-60.07M11.48%63.7M
Effect of exchange rate changes 169.23%36K57.69%-11K64.44%-16K93.03%-34K-29.37%89K25.71%-52K94.27%-26K50.00%-45K-916.67%-488K193.33%126K
End cash Position 64.12%73.17M3.99%85.11M-63.30%31.39M-61.14%53.19M-61.14%53.19M-38.98%44.58M-2.59%81.85M-44.78%85.54M-30.67%136.89M-30.67%136.89M
Free cash flow 34.12%-19.45M-49.81%-38.5M-132.26%-43.92M38.05%-92.72M30.76%-18.59M-3.95%-29.53M26.88%-25.7M68.10%-18.91M-32.66%-149.67M-204.17%-26.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Symbol Mini Chart % Chg
Salesforce
CRM
+8.25%
Adobe
ADBE
+3.88%
Oracle
ORCL
+3.42%
Amazon
AMZN
+2.10%
Coinbase
COIN
+3.32%

Unlock the Full List